Target intelligence / Profile preview

Triosephosphate isomerase 1 pseudogene 1 (TPI1P1)

Target: TPI1P1
Molecular classification: Pseudogene, Non-coding RNA (processed pseudogene)

Overview

Triosephosphate isomerase 1 pseudogene 1 (TPI1P1) is a processed pseudogene, highly homologous to the functional triosephosphate isomerase 1 (TPI1) gene, but contains mutations that prevent it from producing an active enzyme[3]. Pseudogenes like TPI1P1 may arise via gene duplication or retrotransposition but lose protein-coding capability due to frameshifts or premature stop codons[2][3]. TPI1P1 does not serve a known molecular or pharmacological function and is not considered a therapeutic or diagnostic target.

Other names: TPI1P1triosephosphate isomerase pseudogene 1

Beyond the preview

Go deeper on Triosephosphate isomerase 1 pseudogene 1 (TPI1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Triosephosphate isomerase 1 pseudogene 1 (TPI1P1).

Explore the full profile